Details of the Drug Formulations

General Information of Drug (ID: DMCD9YG)

• Drug Name: Prazosin Drug Info
• Synonyms: Furazosin; Justac; Lentopres; Prazocin; Prazosina; Prazosine; Prazosinum; Prazosin HCl; TNP00312; CP-12299; Hypovase (TN); Minipress (TN); Prazosin (INN); Prazosin [INN:BAN]; Prazosina [INN-Spanish]; Prazosine [INN-French]; Prazosinum [INN-Latin]; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone; Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); 1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone

Indication

Disease Entry	ICD 11	Status	REF
Benign prostatic hyperplasia	GA90	Approved	[1]
Congestive heart failure	BD10	Approved	[1]
Hypertension	BA00-BA04	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[2]

• Therapeutic Class: Antihypertensive Agents
• Cross-matching ID:
  PubChem CID: 4893
  ChEBI ID: CHEBI:8364
  CAS Number: 19216-56-9
  TTD ID: D0WV3U
  VARIDT ID: DR00693
  INTEDE ID: DR1330
  ACDINA ID: D00550

Full List of Drug Formulations Containing This Drug

Prazosin 2 mg capsule

Company	Formulation ID	FDA Description
Contract Pharmacal; Mylan Pharamceuticals; RemedyRepack	F17736	D&c red no. 28; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Dimethicone; Gelatin; Shellac
Aphena Pharma Solutions-Tennessee; Mylan Pharamceuticals; PD-Rx Pharmaceuticals	F17737	D&c red no. 28; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Gelatin; Shellac
Greenstone; Pfizer Laboratories	F17734	D&c red no. 28; Sodium lauryl sulfate; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Sucrose; Fd&c red no. 3
A-S Medication Solutions; Aidarex Pharmaceuticals; American Health Packaging; Aphena Pharma Solutions-Tennessee; Bryant Ranch Prepack; Carilion Materials Management; Physicians Total Care; RemedyRepack; State of Florida DOH Central Pharmacy; Teva Pharmaceuticals	F17735	Anhydrous lactose; D&c red no. 28; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Starch, corn

Prazosin 1 mg capsule

Company	Formulation ID	FDA Description
Greenstone; Pfizer Laboratories	F17728	D&c red no. 28; Sodium lauryl sulfate; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Sucrose; Fd&c red no. 3
RemedyRepack	F17730	Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin; Shellac
Contract Pharmacal; Mylan Pharamceuticals; RemedyRepack	F17731	Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Dimethicone; Fd&c green no. 3; Gelatin; Shellac
A-S Medication Solutions; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Mylan Pharamceuticals	F17732	Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin; Shellac
Cardinal Health	F17733	Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Fd&c green no. 3; Gelatin, unspecified; Microcrystalline cellulose; Shellac
A-S Medication Solutions; Aidarex Pharmaceuticals; American Health Packaging; Bryant Ranch Prepack; Lake Eire Medical & Surgical Supply DBA Quality Care Products; TYA Pharmaceuticals; Teva Pharmaceuticals	F17729	Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Titanium dioxide; Starch, corn

Prazosin 5 mg capsule

Company	Formulation ID	FDA Description
Greenstone; Pfizer Laboratories	F17738	D&c red no. 28; Sodium lauryl sulfate; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Sucrose; Fd&c red no. 3
Mylan Pharamceuticals; PD-Rx Pharmaceuticals	F17740	Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Gelatin; Shellac
Mylan Pharamceuticals; RemedyRepack	F17741	Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Dimethicone; Gelatin; Shellac
Teva Pharmaceuticals	F17739	Anhydrous lactose; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Starch, corn

Prazosin Hydrochloride eq 5mg base capsule

Company	Formulation ID	FDA Description
Pfizer	F23334	Hard Gelatin Capsules; Blue 1; Red 3; Red 28; Red 40; Magnesium Stearate; Sodium Lauryl Sulfate; Starch; Sucrose

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) (PREVENT)